FAR Biotech Moves to Madison
FAR Biotech, a computational drug discovery company using proprietary quantum modeling and deep learning AI to tackle high-impact diseases with significant unmet medical need, announced recently that it has moved…
Category Archives: Biotech
Immuto Scientific Announces New Research Collaboration
Immuto Scientific has entered into a research collaboration with an unnamed, U.S.-based multinational animal health company, the company announced today. According to a release, the collaboration is designed to apply…
NorthStar Achieves Commercial-Scale Ac-225 Production, Expands Partnership
NorthStar Medical Radioisotopes has been successful in routinely producing non-carrier-added Actinium-225 (Ac-225) using its electron accelerator-based technology, becoming the first in the industry to do so, the company announced recently….
SHINE Acquires Lantheus’ SPECT Business
SHINE Technologies announced recently that it acquired Lantheus’ SPECT business, which includes the SPECT manufacturing facility in Massachusetts and its portfolio of diagnostic radiopharmaceuticals. “The nuclear medicine supply chain needs…
BrainXell Sees Progress Toward Parkinson’s Disease
BrainXell Therapeutics announced recently preclinical data demonstrating the efficacy of its neuronal therapy called BXT-110 as a potential disease-modifying treatment for Parkinson’s disease. BrainXell Therapeutics is using induced pluripotent stem…
Promega Study Advances Precision Medicine
Promega, alongside several research institutions, announced recently the publication of a new study in Nature Communications, highlighting technological advances that may accelerate breakthroughs in precision medicine. According to a release,…
Cellectar, Ionetix to Partner
Cellectar Biosciences announced today a multi-year supply agreement with Ionetix Corporation, a full-service radioisotope manufacturer. According to a release, Ionetix will provide Cellectar with a clinical and commercial-scale supply of…
Abbott to Acquire Exact Sciences
Exact Sciences is being acquired by Abbott, a global healthcare leader, at a total equity value of approximately $21 billion, the company announced today. “Together with Abbott, we can reach…
BioForward Report Highlights Biohealth Industry
BioForward Wisconsin revealed its first Wisconsin Biohealth Investor Portfolio Report at its Wisconsin Biohealth Summit last month, the organization announced recently. According to a release, the publication provides a comprehensive…
Promega’s OncoMate Receives FDA Approval
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable endometrial carcinoma who…
